-
Pfizer Reprices Lower as Investors Digest Slowing COVID Sales and LOE Impact
16 Dec 2025 21:35 GMT
… previous close of $26.43.
Pfizer Sees $1.5B COVID-19 … Revenue Drop in 2026 Forecast
Pfizer’s 2026 outlook revealed significant … the pandemic’s peak.
Additionally, Pfizer anticipates a year-over-year … trading on December 16, 2025, Pfizer stock was down 3.97% …
-
Pfizer outlook, Humana leadership shake-up, Kraft Heinz's new CEO
16 Dec 2025 21:45 GMT
… to take a look at Pfizer, Humana, and Kraft Heinz. We … ;re going to start with Pfizer. Those shares are under pressure … seeing here is how exactly Pfizer moves on after those hype … in their note is that Pfizer's ability to re …
-
Pfizer shares drop 5% with 2026 revenue projection and long-range outlook
16 Dec 2025 18:32 GMT
… and patent protections expiring, Pfizer is forecasting its 2026 revenue … accelerate the top line,” Pfizer chief financial officer Dave … and the COVID products, Pfizer is projecting an approximate …
In the third quarter, Pfizer’s numbers (PDF) were particularly …
-
Pfizer faces challenging years on fading COVID sales, margin pressure
16 Dec 2025 19:52 GMT
… tries to control costs.
PFIZER FORECASTS MISS WALL STREET … SQUEEZES PRESCRIPTION DRUG MARGINS
Pfizer was the first major … AND BIOSIMILARS DIVISION CREATED
Pfizer also said it will create … of a growth trajectory.”
Pfizer revised its revenue forecast for …
-
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
16 Dec 2025 19:54 GMT
… diluted EPS attributable to Pfizer Inc. common shareholders before … in the business, Pfizer believes presenting operational variances … provides useful information to evaluate Pfizer's results. … diluted EPS attributable to Pfizer Inc. common shareholders …
-
Pfizer Forecasts 2026 Profit: Exclusive Insight on Lower COVID Sales
16 Dec 2025 21:02 GMT
… established markets.
Competitive Landscape: Pfizer faces increased competition from companies … COVID revenue might pressure Pfizer to reallocate investments toward … While this shift presents challenges, Pfizer’s diversified portfolio, ongoing innovation …
-
Pfizer trims 2026 profit forecast amid Covid headwinds and patent cliff pressures
16 Dec 2025 18:24 GMT
… assets.
Through this adjustment, Pfizer now expects profits ranging … following the announcement.
Meanwhile, Pfizer’s R&D … Metsera buyout.
According to Pfizer, Covid vaccine profits are … during a clinical trial.
Pfizer’s cardiometabolic-focused strategy …
-
Pfizer sees flat 2026 sales as it rebuilds drug pipeline
16 Dec 2025 18:31 GMT
… products is still falling; Pfizer forecast sales from these products … for acquisitions that help Pfizer build its pipeline of … billion Metsera acquisition gives Pfizer a stable of promising new … the year ahead for Pfizer,” BMO Capital Markets analyst …
-
Tepid 2026 outlook dents Pfizer shares
16 Dec 2025 21:12 GMT
… on roughly flat revenues.
Pfizer expects 2026 revenues of between … for weight loss drugs.
Pfizer has also identified oncology as … a loss of exclusivity.
Pfizer has maintained a dividend but … .com said the results underscored Pfizer's "painful …
-
Wall Street mostly flat after jobs data signal softening labor market, Pfizer drops 3.3%
16 Dec 2025 18:32 GMT
… AI chips, fell 2.4%.
Pfizer stock dropped 3.3% after …